{"nct_id":"NCT01484275","title":"A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma","status":"COMPLETED","status_verified_date":"2020-01","start_date":"2012-03-01","start_date_type":"ACTUAL","primary_completion_date":"2015-05-12","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}